Study reveals societal stigma and negative stereotypes associated with acne, highlighting the need for greater awareness and understanding of this skin condition.
Verve pauses lead base editing program after safety event, switches focus to follow-up candidate near clinic
Verve Therapeutics is pausing work on its lead gene editing treatment, which was the first time base editing was used to directly alter DNA in
April 3, 2024